|
Soler-Espejo E, Zazo-Luengo BA, Rivera-Caravaca JM, Lopez-Gavez R, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation. J Nutr Health Aging. 2025 Jan;29(1):100430. doi: 10.1016/j.jnha.2024.100430. Epub 2024 Nov 29. PubMed PMID: 39615399.
AÑO: 2025; IF: 4.3
|
39615399
|
Serna MJ, Rivera-Caravaca JM, Lopez-Galvez R, Soler-Espejo E, Lip GYH, Marin F, Roldan V. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients. Rev Esp Cardiol (Engl Ed). 2024 Oct;77(10):835-842. doi: 10.1016/j.rec.2024.02.011. Epub 2024 Mar 7. English, Spanish. PubMed PMID: 38460882.
AÑO: 2024; IF: 5.9
|
|
Piqueras-Sanchez C, Esteve-Pastor MA, Moreno-Fernandez J, Soler-Espejo E, Rivera-Caravaca JM, Roldan V, Marin F. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation. Expert Rev Neurother. 2024 Sep;24(9):913-928. doi: 10.1080/14737175.2024.2379413. Epub 2024 Jul 22. PubMed PMID: 39039686.
AÑO: 2024; IF: 3.4
|
|
Roldan V, Badimon JJ. Does One Size Fits All? Cardiovasc Drugs Ther. 2024 Dec;38(6):1099-1101. doi: 10.1007/s10557-024-07625-6. Epub 2024 Sep 5. No abstract available. PubMed PMID: 39235567.
AÑO: 2024; IF: 3.1
|
|
Soler-Espejo E, Rivera-Caravaca JM, Bru-Canovas JD, Esteve-Pastor MA, Lip GYH, Marin F, Roldan V. Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study. Intern Emerg Med. 2024 Oct;19(7):1941-1948. doi: 10.1007/s11739-024-03701-9. Epub 2024 Jul 4. PubMed PMID: 38965203; PubMed Central PMCID: PMC11467067.
AÑO: 2024; IF: 3.2
|